Geopolitics & Trade

The firm's new ISO 42001 certification signals a major shift towards verifiable, trustworthy AI for the highly regulated life sciences industry.

Amid a 400% surge in ransomware targeting SAP, Onapsis and partners like Microsoft will tackle the security crisis driven by AI and cloud adoption.

February saw 3.8 billion robocalls, a yearly drop. But a rise in daily call rates and massive scam campaigns show the fight is far from over.

With its new FRESHPREY line, premium brand ORIJEN challenges fresh food incumbents, leveraging extreme marketing and a 'WholePrey' philosophy.

Scaled Agile's annual summit pivots to AI, unveiling new research on AI's economic reality and a roadmap for enterprises to become truly 'AI-Native'.

The acquisition of Perfusion Life expands Integration Health's network, aiming to solve critical staffing shortages for life-saving perfusionist roles.

Lionsgate and Scentbird's new John Wick perfume is more than a novelty; it's a strategic play in the booming billion-dollar fandom economy.

A top Molina Healthcare executive is now President at HiLabs, signaling a major push to use AI to fix the flawed data plaguing the health industry.

As AI enters the courtroom, a Legalweek panel tackles the agentic and generative tech transforming complex cases and the urgent ethical dilemmas that follow.

Newly published research brings scientific rigor to the controversial kratom plant, influencing policy from the FDA to statehouses across the nation.

Suave enters Canada exclusively at Walmart, armed with data showing 79% of Canadians would drop premium brands for an affordable, effective alternative.

With a major new investment, Cognito Therapeutics is pushing its non-invasive light and sound therapy for Alzheimer's toward a 2027 market launch.

A new partnership between Always and The Fibroid Foundation aims to break the silence on heavy periods and fibroids, combining product innovation with advocacy.

A new partnership sees Veritone's AI unlock The Washington Post's video vault, aiming to monetize history while protecting journalistic integrity.

A new report reveals why distributors are holding more stock, risking cash flow to battle volatility and win customers in a fiercely competitive market.

IDOC's acquisition of GSRx signals a major strategic move, promising benefits for independent optometrists but raising questions about industry consolidation.

Beating Wall Street estimates with historic gross profits, the chipmaker leverages new capital and key partnerships to push its ultra-low-power tech deeper into AI.

Ituran announces a $30M dividend after a record year, leveraging a unique Israeli tax law to boost shareholder returns and signaling deep confidence.

Investors watch closely as CytoSorbents balances a push for profitability with high-stakes regulatory hurdles for its life-saving blood purification tech.

Investors eye Moody's CEO Rob Fauber's upcoming speech for insights on AI strategy, M&A forecasts, and navigating an increasingly complex global economy.